Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fidia Spa ( (IT:FDA) ) has provided an announcement.
Fidia S.p.A. has issued 1,000,000 new shares to Global Growth Holding Limited following the conversion of one bond from the fourth tranche of its reserved convertible bond with warrants. The new shares, issued at a conversion price of €0.01, are immediately admitted to trading, and the related partial execution of the share capital increase will be filed with the Turin Companies Register in due course.
Following this conversion, the nominal amount subscribed under the POC stands at €1,000,000, with €930,000 of the related capital increase subscribed and seven bonds still outstanding and not yet converted. As a result, Fidia’s share capital rises by €10,000 to €10,777,761.90, and the total number of shares outstanding increases to 52,542,927, modestly diluting existing shareholders while advancing the company’s ongoing financing plan.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in numerical control technology and high-performance integrated milling systems. Its solutions, including numerical controls, high-speed milling machines and CAM software for complex shapes, are used mainly in the automotive mould-making and aerospace sectors, where it covers the entire milling process from programming to finished product.
Average Trading Volume: 1,436,739
Technical Sentiment Signal: Strong Sell
Current Market Cap: €657.3K
For an in-depth examination of FDA stock, go to TipRanks’ Overview page.